Summary

The research team at the LeiCeM Cluster of Excellence is preparing a new study. It builds on the first phase of the Hormones and Health study (HHS), in which researchers from the Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG), Leipzig University and the University of Leipzig Medical Center followed trans people undergoing gender-affirming hormone therapy. The second cohort will be studied over a period of two years, with the study expected to begin in early 2027.

AI summaries can be wrong sometimes—always verify important details using the source article.